ADPT
Price
$6.57
Change
+$0.05 (+0.77%)
Updated
Dec 18, 10:33 AM (EDT)
62 days until earnings call
VIR
Price
$7.34
Change
-$0.22 (-2.91%)
Updated
Dec 17, 04:59 PM (EDT)
64 days until earnings call
Ad is loading...

ADPT vs VIR

Header iconADPT vs VIR Comparison
Open Charts ADPT vs VIRBanner chart's image
Adaptive Biotechnologies
Price$6.57
Change+$0.05 (+0.77%)
Volume$3.06K
CapitalizationN/A
Vir Biotechnology
Price$7.34
Change-$0.22 (-2.91%)
Volume$15.35K
CapitalizationN/A
ADPT vs VIR Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. VIR commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Buy and VIR is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ADPT: $6.52 vs. VIR: $7.35)
Brand notoriety: ADPT: Notable vs. VIR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 141% vs. VIR: 83%
Market capitalization -- ADPT: $962.22M vs. VIR: $1.01B
ADPT [@Biotechnology] is valued at $962.22M. VIR’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADPT and VIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 3 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 4 bearish.
  • VIR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ADPT is a better buy in the short-term than VIR.

Price Growth

ADPT (@Biotechnology) experienced а -2.83% price change this week, while VIR (@Biotechnology) price change was -9.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.61%. For the same industry, the average monthly price growth was +1.51%, and the average quarterly price growth was +3.06%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 18, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-3.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.01B) has a higher market cap than ADPT($962M). ADPT YTD gains are higher at: 33.061 vs. VIR (-26.938).
ADPTVIRADPT / VIR
Capitalization962M1.01B95%
EBITDAN/A-562.68M-
Gain YTD33.061-26.938-123%
P/E RatioN/AN/A-
RevenueN/A62M-
Total CashN/A914M-
Total DebtN/A113M-
TECHNICAL ANALYSIS
Technical Analysis
ADPTVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
82%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with ABCL. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
-3.83%
ABCL - ADPT
53%
Loosely correlated
-2.45%
BEAM - ADPT
52%
Loosely correlated
-1.21%
VIR - ADPT
50%
Loosely correlated
-2.78%
PRME - ADPT
49%
Loosely correlated
-3.00%
CRSP - ADPT
48%
Loosely correlated
+0.88%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with TECH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.78%
TECH - VIR
51%
Loosely correlated
-1.17%
ADPT - VIR
50%
Loosely correlated
-3.83%
AVIR - VIR
49%
Loosely correlated
+1.94%
CRSP - VIR
47%
Loosely correlated
+0.88%
PGEN - VIR
44%
Loosely correlated
+2.46%
More